ATHJF - Antisense Therapeutics Limited

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.09M
Enterprise Value 33.25M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)10.02
Price/Book (mrq)3.22
Enterprise Value/Revenue 37.96
Enterprise Value/EBITDA 6-1.57

Financial Highlights

Fiscal Year
Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 0.00%
Operating Margin (ttm)-509.36%
Management Effectiveness
Return on Assets (ttm)-43.66%
Return on Equity (ttm)-85.68%
Income Statement
Revenue (ttm)407.98k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-74.10%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-2.08M
Diluted EPS (ttm)-0.013
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)1.44M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.68
Book Value Per Share (mrq)0.01
Cash Flow Statement
Operating Cash Flow (ttm)-2.2M
Levered Free Cash Flow (ttm)-1.43M

Trading Information

Stock Price History
Beta 1.08
52-Week Change 3∞%
S&P500 52-Week Change 317.32%
52 Week High 30.047
52 Week Low 30.000
50-Day Moving Average 30.033
200-Day Moving Average 30.037
Share Statistics
Avg Vol (3 month) 35.07k
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Float 94.5M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A